EN
中文 EN
Pipeline & Strategy
Home >Innovation >Pipeline & Strategy
R&D Pipeline
CanSinoBIO is dedicated in innovation and has established a diversified portfolio of product candidates preventing more than 10 diseases, demonstrating strong competitiveness.
Globally Innovative First-in-class in China Pre-clinical
Group ACYW135 Meningococcal Polysaccharide Conjugate Vaccine (CRM197) Indication Expansion (7-17 years old)
Td5cp Adolescent and Adult
Group ACYW135 Meningococcal Polysaccharide Conjugate Vaccine (CRM197) Indication Expansion (18-59 years old)
Recombinant Poliomyelitis Vaccine
PBPV
Recombinant Zoster Vaccine (Adenovirus Vector)
Haemophilus Influenzae Type b Conjugate Vaccine, Freeze-dried
Inhaled Tuberculosis Vaccine (Adenovirus Type 5 Vector)
DT3cP-Hib-MCV4 Combined Vaccine
24-valent Pneumococcal Polysaccharide Conjugate Vaccine (CRM197/TT)
CS-2606 mRNA Multi-valent Influenza Vaccine
CS-2023 Meningococcal Vaccine
Other Combination Vaccine Candidates
Therapeutic Biological Candidates
Strategy
The increasing demand for combination vaccines is expected to drive our business growth.
Meningococcal Vaccine Products
  • Groups A and C Meningococcal Polysaccharide Conjugate Vaccine (CRM197) Menphecia®
  • Group ACYW135 Meningococcal Polysaccharide Conjugate Vaccine (CRM197) Menhycia®
  • CS-2023 Meningococcal Vaccine
Pneumococcal Vaccine Products
  • 13-valent Pneumococcal Polysaccharide Conjugate Vaccine (CRM197/TT) iPneucia®
  • PBPV
  • 24-valent Pneumococcal Polysaccharide Conjugate Vaccine (CRM197/TT)
DTP Vaccine Products
  • Diphtheria, Tetanus and Pertussis (Acellular, Three Components) Combined Vaccine, Adsorbed for infants (below 2 years old) Tripecia®
  • Absorbed Tetanus Vaccine Tetcia®
  • Td5cp Adolescent and Adult
  • DT3cP-Hib-MCV4 Combined Vaccine
Other
  • Inhaled Tuberculosis Vaccine (Adenovirus Type 5 Vector)
  • Recombinant Zoster Vaccine (Adenovirus Vector)
  • Recombinant Poliomyelitis Vaccine
  • Haemophilus Influenzae Type b Conjugate Vaccine, Freeze-dried
  • CS-2606 mRNA Multi-valent Influenza Vaccine
Emergency Infectious Diseases Vaccine
  • Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) Convidecia®
  • Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) for Inhalation Convidecia Air® and XBB.1.5 VARIANT
  • Recombinant Ebola Vaccine (Adenovirus Type 5 Vector)